The Maharashtra Food and Drug Administration (FDA) has cancelled the manufacturing licenses of 10 Ayurvedic drug manufacturers after statewide inspections identified major violations involving manufacturing practices and quality-control requirements. The FDA inspected 434 licensed Ayurvedic drug manufacturing establishments across Maharashtra to assess compliance with the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and Schedule T Good Manufacturing Practices (GMP) requirements for Ayurvedic, Siddha and Unani medicines.

Following the inspections, 135 manufacturers were issued show-cause notices for various violations and instances of non-compliance. The 10 manufacturing licences were permanently cancelled after inspections identified violations considered serious enough to potentially affect the quality, safety and efficacy of medicines and pose a public health…